Exit this survey >>

2018 May 23 ce request VSHP webinar recording 18-023

Default Section

Question Title

* 1. Participant Information. Pharmacists and pharmacy techs: CE will be posted to your NABP CPE account within two weeks following completion of the evaluation.

First name:

Last name:

Email Address:

Phone Number:

Question Title

* 2. Professional Designation

1. Pharmacist

2. Pharmacy Tech

3. Other

Question Title

* 3. For pharmacists and pharmacy technicians. What is your NABP CPE number?

Question Title

* 4. What s your birthdate (month/date only no year)?

	Month	Date born
Birthdate	Birthdate Month menu	Birthdate Date born menu

Question Title

* 5. Program:

	Strongly Agree=5	Agree=4	Neutral	Disagree	Strongly Disagree
Overall, I was satisfied with this course.	Overall, I was satisfied with this course. Strongly Agree=5	Overall, I was satisfied with this course. Agree=4	Overall, I was satisfied with this course. Neutral	Overall, I was satisfied with this course. Disagree	Overall, I was satisfied with this course. Strongly Disagree
My educational needs were met.	My educational needs were met. Strongly Agree=5	My educational needs were met. Agree=4	My educational needs were met. Neutral	My educational needs were met. Disagree	My educational needs were met. Strongly Disagree
The activity will be useful in my practice or service.	The activity will be useful in my practice or service. Strongly Agree=5	The activity will be useful in my practice or service. Agree=4	The activity will be useful in my practice or service. Neutral	The activity will be useful in my practice or service. Disagree	The activity will be useful in my practice or service. Strongly Disagree
Active learning opportunities were incorporated.	Active learning opportunities were incorporated. Strongly Agree=5	Active learning opportunities were incorporated. Agree=4	Active learning opportunities were incorporated. Neutral	Active learning opportunities were incorporated. Disagree	Active learning opportunities were incorporated. Strongly Disagree
Effective delivery techniques were utilized.	Effective delivery techniques were utilized. Strongly Agree=5	Effective delivery techniques were utilized. Agree=4	Effective delivery techniques were utilized. Neutral	Effective delivery techniques were utilized. Disagree	Effective delivery techniques were utilized. Strongly Disagree
I did not perceive any bias or commercialism.	I did not perceive any bias or commercialism. Strongly Agree=5	I did not perceive any bias or commercialism. Agree=4	I did not perceive any bias or commercialism. Neutral	I did not perceive any bias or commercialism. Disagree	I did not perceive any bias or commercialism. Strongly Disagree

Question Title

* 6. Learning Assessment:

	Strongly Agree=5	Agree=4	Neutral	Disagree	Strongly Disagree
The learning assessment questions were reasonable and adequate based on the presentation.	The learning assessment questions were reasonable and adequate based on the presentation. Strongly Agree=5	The learning assessment questions were reasonable and adequate based on the presentation. Agree=4	The learning assessment questions were reasonable and adequate based on the presentation. Neutral	The learning assessment questions were reasonable and adequate based on the presentation. Disagree	The learning assessment questions were reasonable and adequate based on the presentation. Strongly Disagree

Question Title

* 7. Content-Learning Objectives-Pharmacists

	Strongly Agree=5	Agree=4	Neutral=3	Disagree=2	Strongly Disagree=1
Describe the impact of the cost of branded drugs	Describe the impact of the cost of branded drugs Strongly Agree=5	Describe the impact of the cost of branded drugs Agree=4	Describe the impact of the cost of branded drugs Neutral=3	Describe the impact of the cost of branded drugs Disagree=2	Describe the impact of the cost of branded drugs Strongly Disagree=1
Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months.	Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months. Strongly Agree=5	Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months. Agree=4	Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months. Neutral=3	Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months. Disagree=2	Discuss new drugs likely to be reviewed by the FDA in the next 12-18 months. Strongly Disagree=1
Discuss new classes of drugs in development.	Discuss new classes of drugs in development. Strongly Agree=5	Discuss new classes of drugs in development. Agree=4	Discuss new classes of drugs in development. Neutral=3	Discuss new classes of drugs in development. Disagree=2	Discuss new classes of drugs in development. Strongly Disagree=1
Discuss diseases without a current approved treatment that drugs are being developed to treat.	Discuss diseases without a current approved treatment that drugs are being developed to treat. Strongly Agree=5	Discuss diseases without a current approved treatment that drugs are being developed to treat. Agree=4	Discuss diseases without a current approved treatment that drugs are being developed to treat. Neutral=3	Discuss diseases without a current approved treatment that drugs are being developed to treat. Disagree=2	Discuss diseases without a current approved treatment that drugs are being developed to treat. Strongly Disagree=1

Question Title

* 8. Content-Learning Objectives-Pharmacy technicians

	Strongly Agree=5	Agree=4	Neutral=3	Disagree=2	Strongly Disagree=1
Discuss the impact of the cost of branded drugs	Discuss the impact of the cost of branded drugs Strongly Agree=5	Discuss the impact of the cost of branded drugs Agree=4	Discuss the impact of the cost of branded drugs Neutral=3	Discuss the impact of the cost of branded drugs Disagree=2	Discuss the impact of the cost of branded drugs Strongly Disagree=1
List new drugs likely to be reviewed by the FDA in the next 12-18 months	List new drugs likely to be reviewed by the FDA in the next 12-18 months Strongly Agree=5	List new drugs likely to be reviewed by the FDA in the next 12-18 months Agree=4	List new drugs likely to be reviewed by the FDA in the next 12-18 months Neutral=3	List new drugs likely to be reviewed by the FDA in the next 12-18 months Disagree=2	List new drugs likely to be reviewed by the FDA in the next 12-18 months Strongly Disagree=1
List new classes of drugs in development	List new classes of drugs in development Strongly Agree=5	List new classes of drugs in development Agree=4	List new classes of drugs in development Neutral=3	List new classes of drugs in development Disagree=2	List new classes of drugs in development Strongly Disagree=1
Identify diseases without a current approved treatment that drugs are being developed to treat.	Identify diseases without a current approved treatment that drugs are being developed to treat. Strongly Agree=5	Identify diseases without a current approved treatment that drugs are being developed to treat. Agree=4	Identify diseases without a current approved treatment that drugs are being developed to treat. Neutral=3	Identify diseases without a current approved treatment that drugs are being developed to treat. Disagree=2	Identify diseases without a current approved treatment that drugs are being developed to treat. Strongly Disagree=1

Question Title

* 9. Analyze the outcomes of the meeting.

	Strongly Agree=5	Agree=4	Neutral	Disagree	Strongly Disagree
The information presented reinforced my current practice.	The information presented reinforced my current practice. Strongly Agree=5	The information presented reinforced my current practice. Agree=4	The information presented reinforced my current practice. Neutral	The information presented reinforced my current practice. Disagree	The information presented reinforced my current practice. Strongly Disagree
The information presented provided new ideas or information I expect to use.	The information presented provided new ideas or information I expect to use. Strongly Agree=5	The information presented provided new ideas or information I expect to use. Agree=4	The information presented provided new ideas or information I expect to use. Neutral	The information presented provided new ideas or information I expect to use. Disagree	The information presented provided new ideas or information I expect to use. Strongly Disagree
The information presented enhanced my current knowledge base.	The information presented enhanced my current knowledge base. Strongly Agree=5	The information presented enhanced my current knowledge base. Agree=4	The information presented enhanced my current knowledge base. Neutral	The information presented enhanced my current knowledge base. Disagree	The information presented enhanced my current knowledge base. Strongly Disagree
The information presented will improve my practice/patient outcomes.	The information presented will improve my practice/patient outcomes. Strongly Agree=5	The information presented will improve my practice/patient outcomes. Agree=4	The information presented will improve my practice/patient outcomes. Neutral	The information presented will improve my practice/patient outcomes. Disagree	The information presented will improve my practice/patient outcomes. Strongly Disagree
The information presented will cause me to make a change to my practice.	The information presented will cause me to make a change to my practice. Strongly Agree=5	The information presented will cause me to make a change to my practice. Agree=4	The information presented will cause me to make a change to my practice. Neutral	The information presented will cause me to make a change to my practice. Disagree	The information presented will cause me to make a change to my practice. Strongly Disagree
I am committed to making these changes.	I am committed to making these changes. Strongly Agree=5	I am committed to making these changes. Agree=4	I am committed to making these changes. Neutral	I am committed to making these changes. Disagree	I am committed to making these changes. Strongly Disagree

Question Title

* 10. Speaker

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
The speaker demonstrated adequate knowledge of the subject matter.	The speaker demonstrated adequate knowledge of the subject matter. Strongly Agree	The speaker demonstrated adequate knowledge of the subject matter. Agree	The speaker demonstrated adequate knowledge of the subject matter. Neutral	The speaker demonstrated adequate knowledge of the subject matter. Disagree	The speaker demonstrated adequate knowledge of the subject matter. Strongly Disagree
The speaker explained the content clearly and accurately.	The speaker explained the content clearly and accurately. Strongly Agree	The speaker explained the content clearly and accurately. Agree	The speaker explained the content clearly and accurately. Neutral	The speaker explained the content clearly and accurately. Disagree	The speaker explained the content clearly and accurately. Strongly Disagree
The speaker was responsive to questions.	The speaker was responsive to questions. Strongly Agree	The speaker was responsive to questions. Agree	The speaker was responsive to questions. Neutral	The speaker was responsive to questions. Disagree	The speaker was responsive to questions. Strongly Disagree
The material was presented in a fair and impartial manner.	The material was presented in a fair and impartial manner. Strongly Agree	The material was presented in a fair and impartial manner. Agree	The material was presented in a fair and impartial manner. Neutral	The material was presented in a fair and impartial manner. Disagree	The material was presented in a fair and impartial manner. Strongly Disagree

Question Title

* 11. What were the strengths of the program?

Question Title

* 12. What would you improve with the program? Please address any disagree or strongly disagree responses from above.

Question Title

* 13. What type of guides or courses would you like to see presented in the future?

Question Title

* 14. Other comments: